*The following content is generated by AI and is for reference only.
Overview
Empagliflozin is a selective SGLT2 inhibitor used in diabetes management. Synthesized via multi-step organic chemistry, its molecular formula is C21H25NO8 (CAS: 864075-96-1).
Application
- Pharmaceutical manufacturing for Type 2 Diabetes treatment.
- Combination therapy with insulin or metformin.
- Cardiovascular risk reduction in diabetic patients.
Precautions
Contraindicated in severe renal impairment and pregnancy. Store in cool, dry conditions below 25°C to maintain stability and prevent hydrolysis.